This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
$1 buys you full access to ALL of TheStreet's Subscription Services! Learn More

Mead Johnson Has a Winning Formula

Stocks in this article: MJNBMSMS

In fact, MJN sells products it calls adult nutrition and milk nutritional enhancers. Not surprisingly, the company also has products for expecting and breast-feeding moms, as well as specialty lines for children with special medical needs and for the management metabolic disorders.

Today, the company sells several metabolic formulas designed for the dietary management of specific conditions, including phenylketonuria, maple syrup urine disease and homocystinuria, among others. It sells its products to mothers, health-care professionals and retailers in 50 countries in North America, Europe, Asia and Latin America.

The company, which was founded in 1905 and is headquartered in Glenview, Ill., also offers a variety of specialized infant formulas that are designed specifically for feeding premature or low-birth-weight infants.

This focused-enough-yet- wide-enough product line has made a significant difference to the company's operating results, financials and the total returns of its shareholders.

The trailing 12-month return on equity is a stellar (are you sitting down) 1,240%! As of last March 31, MJN has an operating margin of over 23% and a profit margin of around 15.5%. Its revenue has grown to nearly $4 billion and it sports a market cap of around $16 billion.

As of March 31, Morgan Stanley (MS) owned more than 5% of MJN's outstanding shares of. Another institutional holder of almost 5% was Fidelity Investments , and the Vanguard Group owns another 4.6% of the company's stock.

Frankly, I was somewhat surprised that CEO Peter Jakobsen isn't a substantial owner of shares. As of May 27, outgoing CEO Stephen Golsby exercised 175,000 stock options at $26.58 a share, then he sold 93,478 shares at $86.19 for a 200%-plus profit.


Then I read a company press release from April 30 announcing that Peter K. Jakobsen, 51, had been named as president and CEO by the company's board, following the company's annual meeting the same day in Chicago. Golsby had previously announced his retirement.

"Throughout his career at Mead Johnson, Kasper has displayed a keen understanding of our operations, our customers, our markets, and the issues that drive this industry," said Jim Cornelius, the company's chairman.

2 of 3

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!

Markets

DOW 17,827.75 +12.81 0.07%
S&P 500 2,072.83 +5.80 0.28%
NASDAQ 4,787.3170 +29.0650 0.61%

Brokerage Partners

Rates from Bankrate.com

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs